|
Market Closed -
Euronext Bruxelles
01:55:00 22/08/26 am AEST
|
After hours 05:59:59 am | |||
| 221.70 EUR | +1.74% |
|
221.50 | -0.09% |
| 20/08 | Cancer vaccines finally garner the spotlight |  |
| 19/08 | Danish Pharma H. Lundbeck Expects No Slowdown for Primary Growth Driver Brands | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UCB | Biopharmaceuticals | +1.74% | +1.19% | -7.08% | +13.58% | +123.89% | 48.52B |  | |  |
- Stock Market
- Stocks
- UCB Stock
- Charts UCB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
